SDS Biotech K.K. reported consolidated earnings results for the period ended December 31, 2015. For the year, the company reported net sales of JPY 16,719 million against JPY 15,740 million a year ago. Operating income was JPY 1,637 million against JPY 1,565 million a year ago. Ordinary income was JPY 1,342 million against JPY 1,386 million a year ago. Net income was JPY 944 million or JPY 120.64 per basic and diluted share against JPY 813 million or JPY 103.90 per basic and diluted share a year ago. Net assets per share as of December 31, 2015 were JPY 861.44 per share compared to JPY 734.81 per share, at the end of December 31, 2014. Net income before taxes was JPY 1,324,311,000. Net cash used in operating activities was JPY 740,215,000. Purchase of property, plant and equipment was JPY 210,388,000 and purchase of intangible assets was JPY 55,247,000.

The company provided consolidated earnings guidance for the full year ending March 31, 2016. For the year, the company expects to report net sales of JPY 20,880 million, operating income of JPY 2,170 million, ordinary income of JPY 1,800 million and net income of JPY 1,100 million or JPY 140.46 per share.

The company also provided dividend guidance for the full year ending March 31, 2016. For the year, the company expects year-end dividend of JPY 15.00 per share compared to paid year-end dividend of JPY 10.00 per share a year ago.